{"url_path":"/sec/ptpi/10-q/2026/item-1","section_key":"item-1","section_title":"Item 1 LEGAL PROCEEDINGS.","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-13","source_url":"https://www.sec.gov/Archives/edgar/data/1815903/0001104659-26-060359-index.html","accession_number":"0001104659-26-060359","cik":"0001815903","ticker":"PTPI","issuer_name":"Petros Pharmaceuticals, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1815903/0001104659-26-060359-index.html","primary_entity_key":"0001815903","primary_entity_name":"Petros Pharmaceuticals, Inc."},"word_count":58,"has_tables":true,"body_markdown":"ITEM 1. LEGAL PROCEEDINGS.\n\nFrom time to time, we may become involved in legal proceedings or be subject to claims arising in the ordinary course of business.\n\nThe information set forth in Note 9 Commitments and Contingencies of the Notes to Condensed Consolidated Financial Statements of this Quarterly Report on Form 10-Q is incorporated by reference herein.\n\n​"}